Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024. https://doi.org/10.3322/caac.21834.
National Cancer Institute. https://cancerstatisticscenter.cancer.org. Accessed April 3, 2024.
Morgan E, Arnold M, Camargo MC, Gini A, Kunzmann AT, Matsuda T et al. The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: A population-based modeling study. EClinicalMedicine. (2022) 47:101404. https://doi.org/10.1016/j.eclinm.2022.101404
Sato Y, Okamoto K, Kawano Y, et al. Novel biomarkers of gastric cancer: current research and future perspectives. J Clin Med. 2023;12:4646.
CAS PubMed PubMed Central Google Scholar
Arnold M, Park JY, Camargo MC, Lunet N, Forman D, Soerjomataram I. Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035. Gut. 2020;69:823–9. https://doi.org/10.1136/gutjnl-2019-320234.
Anand P, Kunnumakara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS, et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res. 2008;25:2097–116. https://doi.org/10.1007/s11095-008-9661-9.
CAS PubMed PubMed Central Google Scholar
Lauren P. The two histological main types of gastric carcinoma: diffuse and So-Called Intestinal-Type carcinoma. An attempt at a Histo-Clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.
Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric Cancer epidemiology. Lancet. 1975;2:58–60.
Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric Cancer. N Engl J Med. 2001;345:784–9.
Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell. 2006; 124:837–48. https://doi.org/10.1016/j.cell.2006.02.017.
Petersen C, Round JL. Defining dysbiosis and its influence on host immunity and disease. Cell Microbiol. 2014;16:1024e33.
Hugon P, Dufour J-C, Colson P, Fournier P-E, Sallah K, Raoult D. A comprehensive repertoire of prokaryotic species identified in human beings. Lancet Infect Dis. 2015;15:1211–9. https://doi.org/10.1016/S1473-3099(15)00293-5.
Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J. 2017;474:1823–36. https://doi.org/10.1042/BCJ20160510.
LeBlanc JG, Milani C, de Giori GS, Sesma F, van Sinderen D, Ventura M. Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr Opin Biotechnol. 2013;24:160–8. https://doi.org/10.1016/j.copbio.2012.08.005.
Musso G, Gambino R, Cassader M. Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes Care. 2010;33:2277–84. https://doi.org/10.2337/dc10-0556.
PubMed PubMed Central Google Scholar
Chakrabarti SK, Chattopadhyay D. Ageless harmony: decoding the microbiome–stem cell nexus in aging. Acad Mol Biology Genomics. 2024;1. https://doi.org/10.20935/AcadMolBioGen7433.
Yu J, Li L, Tao X, Chen Y, Dong D. Metabolic interactions of host-gut microbiota: new possibilities for the precise diagnosis and therapeutic discovery of Gastrointestinal cancer in the future-A review. Clin Reviews Oncology/Hematology. 2024;203:104480.
Arya P, Vadhwana B, Tarazi M. Microbial dysbiosis in gastric cancer: association or causation? Best practice & research clinical gastroenterology 72 (2024) 101961. https://doi.org/10.1016/j.bpg.2024.101961.0
Yu Y, Ba B, Pengfei C, Jing C, Aruna M, Lei Y, Fan Y, Hongwei C. Advances in the study of the role of gastric microbiota in the progression of gastric cancer. Microb Pathog, https://doi.org/10.1016/j.micpath.2024.107240
Dai D, Yang Y, Yu J, et al. Interactions between gastric microbiota and metabolites in gastric cancer. Cell Death Dis. 2021;12:1104.
CAS PubMed PubMed Central Google Scholar
Yang Y, Dai D, Jin W, et al. Microbiota and metabolites alterations in proximal and distal gastric cancer patients. J Transl Med. 2022;20:439.
CAS PubMed PubMed Central Google Scholar
Chen XH, Wang A, Chu AN, et al. Mucosa-associated microbiota in gastric cancer tissues compared with non-cancer tissues. Front Microbiol. 2019;10:1261.
PubMed PubMed Central Google Scholar
Wang Y, Qiu X, Chu A, Chen J, Wang L, Sun X, Wang B, Yuan Y, Gong Y. Advances in 16S rRNA-Based microbial biomarkers for gastric Cancer diagnosis and prognosis. Microb Biotechnol. 2025;18: e70115 1 of 28. https://doi.org/10.1111/1751-7915.70115.
Lane DJ, Pace GJ, Olsen DA, Stahl ML, Sogin NR, Pace NR. 1985. Rapid Determination of 16S Ribosomal RNA Sequences for Phylogenetic Analyses. Proceedings of the National Academy of Sciences of the United States of America 1985; 82, no. 20: 6955–6959.
Olsen GJ, Lane SJ, Giovannoni NR, Pace DA, Stahl DA. Microbial ecology and evolution: A ribosomal RNA approach. Annu Rev Microbiol. 1986;40:337–65.
Nikitina D, Lehr R, Vilchez-Vargas, et al. Comparison of genomic and transcriptional Microbiome analysis in gastric Cancer patients and healthy individuals. World J Gastroenterol. 2023;29:7: 1202–18.
CAS PubMed PubMed Central Google Scholar
Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, et al. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022;7:3.
PubMed PubMed Central Google Scholar
Xie Z, Wang Y, Yang G, Han J, Zhu L, Li L, et al. The role of the Hippo pathway in the pathogenesis of inflammatory bowel disease. Cell Death Dis. 2021;12:79.
PubMed PubMed Central Google Scholar
Shahin, Javanmard. Kayhan ertürk. Activation of YAP/TAZ by gut microbiota via Wnt/β-catenin signaling in cancer development. Acad Mol Biology Genomics 2025:1–12. https://doi.org/10.20935/AcadMolBioGen7642
Schistosomes. liver flukes, and Helicobacter pylori. In: IARC monographs on the evaluation of carcinogenic risks to humans, vol. 61. pp. 1–241.
Lertpiriyapong K, Whary MT, Muthupalani S, et al. Gastric colonization with a restricted commensal microbiota replicates the promotion of neoplastic lesions by diverse intestinal microbiota in the helicobacter pylori INS-GAS mouse model of gastric carcinogenesis. Gut. 2014;63:54–63.
Kwon S-K, Park JC, Kim KH, et al. Human gastric microbiota transplantation recapitulates premalignant lesions in germ-free mice. Gut. 2022;71:1266–76.
Long Y, Tang L, Zhou Y, Zhao S, Zhu H. Causal relationship between gut microbiota and cancers: a two–sample Mendelian randomization study. BMC Med. 2023;21:66. https://doi.org/10.1186/s12916-023-02761-6.
PubMed PubMed Central Google Scholar
Lahner E, Zagari RM, Zullo A, Di Sabatino A, Meggio A, Cesaro P, et al. Chronic atrophic gastritis: natural history, diagnosis, and therapeutic management. A position paper by the Italian society of hospital gastroenterologists and digestive endoscopists [AIGO], the Italian society of digestive endoscopy [SIED], the Italian society of gastroenterology [SIGE], and the Italian society of internal medicine [SIMI]. Dig Liver Dis. 2019;51:1621–32. https://doi.org/10.1016/j.dld.2019.09.016.
Yu G, Torres J, Hu N, Medrano-Guzman R, Herrera-Goepfert R, Humphrys MS, Wang L, Wang C, Ding T, Ravel J, et al. Molecular characterization of the human stomach microbiota in gastric Cancer patients. Front Cell Infect Microbiol. 2017;7:302.
PubMed PubMed Central Google Scholar
Hsieh YY, Tung SY, Pan HY, Yen CW, Xu HW, Lin YJ, Deng YF, Hsu WT, Wu CS, Li C. Increased abundance of Clostridium and Fusobacterium in gastric microbiota of patients with gastric Cancer in Taiwan. Sci Rep. 2018;8:158.
PubMed PubMed Central Google Scholar
Wang L, Zhou J, Xin Y, Geng C, Tian Z, Yu X, Dong Q. Bacterial overgrowth and diversification of microbiota in gastric Cancer. Eur J Gastroenterol Hepatol. 2016;28:261–6.
CAS PubMed PubMed Central Google Scholar
Liu X, Shao L, Liu X, Ji., Mei Y, Cheng Y, Liu F, Yan C, Li L, Ling Z. Alterations of gastric mucosal microbiota across different stomach microhabitats in a cohort of 276 patients with gastric Cancer. EBio Med. 2019;40:336–48.
Li Y, Hu Y, Zhan X, Song Y, Xu M, Wang S, Huang X, Xu ZZ. Meta-Analysis reveals Helicobacter pylori mutual exclusivity and reproducible gastric Microbiome alterations during gastric carcinoma progression. Gut Microbes. 2023;15:2197835.
PubMed PubMed Central Google Scholar
Guo Y, Zhang Y, Gerhard M, Gao JJ, Mejias-Luque R, Zhang L, Vieth M, Ma JL, Bajbouj M, Suchanek S, et al. Effect of Helicobacter pylori on Gastrointestinal microbiota: A Population-Based study in linqu, a High-Risk area of gastric Cancer. Gut. 2020;69:1598–607.
de Assumpcao PP, Araujo TMT, de Assumpcao PB, Barra WF, Khayat AS, Assumpcao CB, Ishak G, Nunes DN, Dias-Neto E, Coelho LGV. Suicide journey of H. Pylori through gastric carcinogenesis: the role of Non-H. Pylori Microbiome and potential consequences for clinical practice. Eur J Clin Microbiol Infect Dis. 2019;38:1591–7.
Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F, Perez-Perez G, Blaser MJ, Relman DA. Molecular Analysis of the Bacterial Microbiota in the Human Stomach. Proc. Natl. Acad. Sci. USA 2006, 103, 732–737. Early Stages of Carcinogenesis. Infect. Immun. 2017, 85, e00031-17.
Thorell K, Bengtsson-Palme J, Liu OH, Palacios Gonzales RV, Nookaew I, Rabeneck L, Paszat L, Graham DY, Nielsen J, Lundin SB, et al. In vivo analysis of the viable microbiota and Helicobacter pylori transcriptome in gastric infection and early stages of carcinogenesis. Infect Immun. 2017;20:85:e00031–17. https://doi.org/10.1128/IAI.00031-17. PMID: 28694295; PMCID: PMC5607399.
Ai B, Mei Y, Liang D, Wang T, Cai H, Yu D. Uncovering the special microbiota associated with occurrence and progression of gastric Cancer by using RNA-Sequencing. Sci Rep. 2023;13:5722.
Comments (0)